Stay updated on Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.

Latest updates to the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision note updated to v3.4.1, replacing v3.4.0. No changes to study content or endpoints are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedIntroduced a glossary toggle and updated metadata to display Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4. This is an internal site revision and does not affect the study details or patient information.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a Locations section with Surrey (Royal Marsden NHS Foundation Trust, Sutton, Surrey); updated the page revision to v3.3.3 and removed the previous Surrey Locations entry and HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Publications note was updated to indicate PubMed automatic population and possible non-study relevance. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.